Historical Valuation
Tenet Healthcare Corp (THC) is now in the Fair zone, suggesting that its current forward PE ratio of 12.23 is considered Fairly compared with the five-year average of 11.70. The fair price of Tenet Healthcare Corp (THC) is between 170.60 to 225.64 according to relative valuation methord.
Relative Value
Fair Zone
170.60-225.64
Current Price：200.66
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Tenet Healthcare Corp (THC) has a current Price-to-Book (P/B) ratio of 4.37. Compared to its 3-year average P/B ratio of 4.41 , the current P/B ratio is approximately -1.01% higher. Relative to its 5-year average P/B ratio of 17.27, the current P/B ratio is about -74.72% higher. Tenet Healthcare Corp (THC) has a Forward Free Cash Flow (FCF) yield of approximately 8.57%. Compared to its 3-year average FCF yield of 12.20%, the current FCF yield is approximately -29.74% lower. Relative to its 5-year average FCF yield of 15.36% , the current FCF yield is about -44.22% lower.
P/B
Median3y
4.41
Median5y
17.27
FCF Yield
Median3y
12.20
Median5y
15.36
Competitors Valuation Multiple
AI Analysis for THC
The average P/S ratio for THC competitors is 0.96, providing a benchmark for relative valuation. Tenet Healthcare Corp Corp (THC.N) exhibits a P/S ratio of 0.80, which is -16.82% above the industry average. Given its robust revenue growth of 3.26%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for THC
1Y
3Y
5Y
Market capitalization of THC increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of THC in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is THC currently overvalued or undervalued?
Tenet Healthcare Corp (THC) is now in the Fair zone, suggesting that its current forward PE ratio of 12.23 is considered Fairly compared with the five-year average of 11.70. The fair price of Tenet Healthcare Corp (THC) is between 170.60 to 225.64 according to relative valuation methord.
What is Tenet Healthcare Corp (THC) fair value?
THC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Tenet Healthcare Corp (THC) is between 170.60 to 225.64 according to relative valuation methord.
How does THC's valuation metrics compare to the industry average?
The average P/S ratio for THC's competitors is 0.96, providing a benchmark for relative valuation. Tenet Healthcare Corp Corp (THC) exhibits a P/S ratio of 0.80, which is -16.82% above the industry average. Given its robust revenue growth of 3.26%, this premium appears unsustainable.
What is the current P/B ratio for Tenet Healthcare Corp (THC) as of Jan 10 2026?
As of Jan 10 2026, Tenet Healthcare Corp (THC) has a P/B ratio of 4.37. This indicates that the market values THC at 4.37 times its book value.
What is the current FCF Yield for Tenet Healthcare Corp (THC) as of Jan 10 2026?
As of Jan 10 2026, Tenet Healthcare Corp (THC) has a FCF Yield of 8.57%. This means that for every dollar of Tenet Healthcare Corp’s market capitalization, the company generates 8.57 cents in free cash flow.
What is the current Forward P/E ratio for Tenet Healthcare Corp (THC) as of Jan 10 2026?
As of Jan 10 2026, Tenet Healthcare Corp (THC) has a Forward P/E ratio of 12.23. This means the market is willing to pay $12.23 for every dollar of Tenet Healthcare Corp’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Tenet Healthcare Corp (THC) as of Jan 10 2026?
As of Jan 10 2026, Tenet Healthcare Corp (THC) has a Forward P/S ratio of 0.80. This means the market is valuing THC at $0.80 for every dollar of expected revenue over the next 12 months.